goodrx holdings inc. - GDRX
GDRX
Close Chg Chg %
4.24 0.08 1.89%
Closed Market
4.32
+0.08 (1.89%)
Volume: 1.84M
Last Updated:
May 9, 2025, 4:00 PM EDT
Company Overview: goodrx holdings inc. - GDRX
GDRX Key Data
| Open $4.24 | Day Range 4.22 - 4.47 |
| 52 Week Range 3.68 - 9.26 | Market Cap $1.51B |
| Shares Outstanding 357.17M | Public Float 83.51M |
| Beta 1.25 | Rev. Per Employee N/A |
| P/E Ratio 57.07 | EPS $0.08 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.49M |
GDRX Performance
| 1 Week | -7.69% | ||
| 1 Month | -2.26% | ||
| 3 Months | -14.29% | ||
| 1 Year | -34.55% | ||
| 5 Years | N/A |
GDRX Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
18
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for Goodrx Holdings Inc. - GDRX
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Goodrx Holdings Inc. - GDRX
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 24, 2025 | Idea Men LLC Director | N/A | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $4.2 per share | 0.00 |
| Mar 24, 2025 | Idea Men LLC Director | 7,000,000 | Conversion of derivative security | 0.00 |
| Mar 17, 2025 | Scott W. Wagner Director | 125,154 | Bona fide gift | 0.00 |
| Mar 17, 2025 | Scott W. Wagner Director | 189,386 | Bona fide gift | 0.00 |
| Mar 17, 2025 | Scott W. Wagner Director | 253,618 | Bona fide gift | 0.00 |
| Mar 11, 2025 | Romin Nabiey Chief Accounting Officer | 106,874 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.61 per share | 492,689.14 |
| Mar 11, 2025 | Romin Nabiey Chief Accounting Officer | 105,449 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.61 per share | 486,119.89 |
| Mar 11, 2025 | Romin Nabiey Chief Accounting Officer | 107,682 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 11, 2025 | Romin Nabiey Chief Accounting Officer | 109,640 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 11, 2025 | Romin Nabiey Chief Accounting Officer | 61,205 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 11, 2025 | Romin Nabiey Chief Accounting Officer | 26,787 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2025 | Christopher A. McGinnis See Remarks | 1,096,937 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Christopher A. McGinnis See Remarks | 716,479 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Wendy Barnes See Remarks; Director | 1,842,374 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Wendy Barnes See Remarks; Director | 2,828,232 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Wendy Barnes See Remarks; Director | 409,416 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 24, 2025 | Scott W. Wagner Director | 94,182 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 6, 2025 | Ronald Earl Bruehlman Director | 32,284 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 6, 2025 | Douglas Joseph Hirsch Director | 154,338 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 11, 2024 | Julie Marie B. Bradley Director | 126,117 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |